Literature DB >> 12875764

Myocardial velocity gradient as a noninvasively determined index of left ventricular diastolic dysfunction in patients with hypertrophic cardiomyopathy.

Tomoko Kato1, Akiko Noda, Hideo Izawa, Takao Nishizawa, Fuji Somura, Akira Yamada, Kohzo Nagata, Mitsunori Iwase, Akimasa Nakao, Mitsuhiro Yokota.   

Abstract

OBJECTIVES: We investigated the utility of the peak negative myocardial velocity gradient (MVG) derived from tissue Doppler imaging (TDI) for evaluation of diastolic dysfunction in patients with hypertrophic cardiomyopathy (HCM).
BACKGROUND: Hypertrophic cardiomyopathy is characterized by impaired diastolic function with abnormal stiffness and prolonged relaxation. However, it remains difficult to evaluate these defects noninvasively.
METHODS: Both TDI and conventional echocardiography were performed in 36 patients with HCM and in 47 control subjects. Left ventricular (LV) pressure was measured simultaneously in all HCM patients and in 26 controls.
RESULTS: The peak negative MVG occurred soon after the isovolumic relaxation period during the initial phase of rapid filling (auxotonic relaxation). It was significantly smaller in HCM patients than in control subjects (2.32 +/- 0.52/s vs. 4.82 +/- 1.15/s, p < 0.0001); the cutoff value for differentiation between all HCM patients and 47 normal individuals was determined as 3.2/s. Both the left ventricular end-diastolic pressure (LVEDP) (19.6 +/- 6.1 mm Hg vs. 6.5 +/- 1.7 mm Hg, p < 0.0001) and the time constant of LV pressure decay during isovolumic diastole (tau) (44.0 +/- 6.7 ms vs. 32.1 +/- 5.5 ms, p < 0.0001) were increased in HCM patients compared with controls. The peak negative MVG was negatively correlated with both LVEDP (r = -0.75, p < 0.0001) and tau (r = -0.58, p < 0.0001).
CONCLUSIONS: A reduced peak negative MVG reflects both prolonged relaxation and elevated LVEDP. The peak negative MVG might thus provide a noninvasive index of diastolic function, yielding unique information about auxotonic relaxation in patients with HCM.

Entities:  

Mesh:

Year:  2003        PMID: 12875764     DOI: 10.1016/s0735-1097(03)00573-4

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  8 in total

1.  Three-dimensional echocardiographic quantitative evaluation of left ventricular diastolic function using analysis of chamber volume and myocardial deformation.

Authors:  Chattanong Yodwut; Roberto M Lang; Lynn Weinert; Homaa Ahmad; Victor Mor-Avi
Journal:  Int J Cardiovasc Imaging       Date:  2012-06-30       Impact factor: 2.357

Review 2.  Heart failure with preserved ejection fraction - unwinding the diagnosis mystique.

Authors:  Muhammad Asrar Ul Haq; Vivek Mutha; Nima Rudd; David L Hare; Chiew Wong
Journal:  Am J Cardiovasc Dis       Date:  2014-10-11

Review 3.  Important advances in technology: echocardiography.

Authors:  Sherif F Nagueh; Miguel A Quiñones
Journal:  Methodist Debakey Cardiovasc J       Date:  2014 Jul-Sep

Review 4.  Echocardiographic evaluation of left ventricular diastolic function: an update.

Authors:  Dimitrios Maragiannis; Sherif F Nagueh
Journal:  Curr Cardiol Rep       Date:  2015-02       Impact factor: 2.931

5.  Cardiac tissue Doppler imaging in sports medicine.

Authors:  Anne Krieg; Jürgen Scharhag; Wilfried Kindermann; Axel Urhausen
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

6.  Multichannel pulsed Doppler signal processing for vascular measurements in mice.

Authors:  Anilkumar K Reddy; Sridhar Madala; Alan D Jones; Walter A Caro; John F Eberth; T Thuy Pham; George E Taffet; Craig J Hartley
Journal:  Ultrasound Med Biol       Date:  2009-10-24       Impact factor: 2.998

7.  Echocardiographic evaluation of diastolic heart failure.

Authors:  Queenie Lo; Liza Thomas
Journal:  Australas J Ultrasound Med       Date:  2015-12-31

Review 8.  Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.

Authors:  Prathap Kanagala; Iain B Squire; Leong L Ng; Gerry P McCann
Journal:  Int J Cardiol Heart Vasc       Date:  2015-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.